Phase 1 Diabetic peripheral neuropathic pain Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)
Florida A&M University20 enrolled1 locationNCT07298408
Recruiting
Phase 1
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
Diabetic peripheral neuropathic pain
Shandong Suncadia Medicine Co., Ltd.168 enrolled2 locationsNCT07377721
Recruiting
Phase 1
MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
Diabetic peripheral neuropathic pain
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.24 enrolled1 locationNCT06361108